Mandate

If Skadeförsäkring Holding AB (publ) issues SEK 1 000 000 000 Tier-1

April 26, 2018 Banking and Finance

If Skadeförsäkring Holding AB (publ) has issued a subordinated loan in an amount of SEK 1 000 000 000.

The bonds are qualified to be included in the If group’s capital base as Tier-1 capital pursuant to the Solvency 2 framework. The bonds are perpetual instruments without a due date and without the right to premature redemption during the first 5 years. The nominal amount may, according to the terms and conditions of the bond, be either wholly or in part depreciated (permanently or temporarily) or converted to equity. The bonds are subject to a variable interest rate of 2.75 per cent above three-month STIBOR. The bonds have been listed on the Luxembourg Stock Exchange. 

If Skadeförsäkring Holding AB (publ) is the parent company within the If group and is owned, in turn, by the Finnish listed company Sampo plc.   

Vinge has advised If Holding as a result of the issuance of the loan whereas the arranging banks were represented by Clifford Chance as well as Hammarskiöld & Co. Vinge’s team consisted of, among other, responsible partner Fabian Ekeblad, Paulina Malmberg (project manager), Josefin Larsson (banking and finance), Isabelle Jengsell (banking and finance) and Maria Schultzberg (tax).

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025